种子简介

种子名称： Lecturio - Pharmacology
文件类型： 视频
文件数目： 186个文件
文件大小： 5.43 GB
收录时间： 2019-9-11 20:51
已经下载： 3次
资源热度： 94
最近下载： 2024-6-26 07:38

下载BT种子文件

下载Torrent文件(.torrent) 立即下载

磁力链接下载

magnet:?xt=urn:btih:6a363264abcc5e0159e968cb8ec1b1ae7460caf6&dn=Lecturio - Pharmacology 复制链接到迅雷、QQ旋风进行下载，或者使用百度云离线下载。

喜欢这个种子的人也喜欢

种子包含的文件

Lecturio - Pharmacology.torrent

01. Antimicrobial Pharmacology/01.01 Overview – Cell Wall Synthesis Inhibitors (Antibiotics).mp46.9MB

01. Antimicrobial Pharmacology/01.02 Penicillins – Cell Wall Synthesis Inhibitors (Antibiotics).mp430.16MB

01. Antimicrobial Pharmacology/01.03 Cephalosporins – Cell Wall Synthesis Inhibitors (Antibiotics).mp420.16MB

01. Antimicrobial Pharmacology/01.04 Carbapenems – Cell Wall Synthesis Inhibitors (Antibiotics).mp46.95MB

01. Antimicrobial Pharmacology/01.05 Vancomycin, Bacitracin and Daptomycin – Cell Wall Synthesis Inhibitors (Antibiotics).mp419.69MB

01. Antimicrobial Pharmacology/01.06 Overview – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp433.48MB

01. Antimicrobial Pharmacology/01.07 Linezolid, Streptogramins and Chloramphenicol – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp430.75MB

01. Antimicrobial Pharmacology/01.08 Macrolides and Ketolides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp424.42MB

01. Antimicrobial Pharmacology/01.09 Tetracyclines – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp423.32MB

01. Antimicrobial Pharmacology/01.10 Aminoglycosides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp436.91MB

01. Antimicrobial Pharmacology/01.11 Quiz Questions and Case Studies – Antibacterial Agents (Antibiotics).mp447.83MB

01. Antimicrobial Pharmacology/02.01 Overview – Antimetabolites.mp45.57MB

01. Antimicrobial Pharmacology/02.02 Sulfonamides, Trimethoprim and Fluoroquinolones – Antimetabolites.mp456.7MB

01. Antimicrobial Pharmacology/02.03 Case Studies – Antimetabolites.mp422.13MB

01. Antimicrobial Pharmacology/02.04 Overview – Antimycobacterial Agents.mp46.48MB

01. Antimicrobial Pharmacology/02.05 Antituberculosis Drugs – Antimycobacterial Agents.mp441.65MB

01. Antimicrobial Pharmacology/02.06 Treatment Regimens for Mycobacterium Tuberculosis, Leprosy and Other Infections – Antimycobacterial Agents.mp424.91MB

01. Antimicrobial Pharmacology/02.07 Case Studies – Antimycobacterial Agents.mp438.87MB

01. Antimicrobial Pharmacology/03.01 Overview – Antifungals.mp44.88MB

01. Antimicrobial Pharmacology/03.02 Azoles – Antifungals.mp430.32MB

01. Antimicrobial Pharmacology/03.03 Polyenes – Antifungals.mp430.99MB

01. Antimicrobial Pharmacology/03.04 Flucytosine (5-Fluorocytosine5-FU) – Antifungals.mp410.02MB

01. Antimicrobial Pharmacology/03.05 Echinocandins and Squalene Epoxidase Inhibitor (Terbinafine) – Antifungals.mp413.45MB

01. Antimicrobial Pharmacology/03.06 Questions – Antifungals.mp418.86MB

01. Antimicrobial Pharmacology/04.01 Overview – Antiviral Drugs.mp416.95MB

01. Antimicrobial Pharmacology/04.02 Anti-HIV Agents Fusion Inhibitors – Antiviral Drugs.mp49.62MB

01. Antimicrobial Pharmacology/04.03 Anti-HIV Agents Nucleoside Reverse Transcriptase Inhibitors (NRTI) – Antiviral Drugs.mp457.3MB

01. Antimicrobial Pharmacology/04.04 Anti-HIV Agents Reverse Transcriptase Inhibitors (NNRTI) – Antiviral Drugs.mp431.61MB

01. Antimicrobial Pharmacology/04.05 Anti-HIV Agents Integrase Strand Transfer Inhibitors – Antiviral Drugs.mp415.16MB

01. Antimicrobial Pharmacology/04.06 Anti-HIV Agents Protease Inhibitors – Antiviral Drugs.mp449.02MB

01. Antimicrobial Pharmacology/04.07 Anti-HIV Agents CCR5 Antagonist – Antiviral Drugs.mp414.46MB

01. Antimicrobial Pharmacology/04.08 Questions about Anti-HIV Agents – Antiviral Drugs.mp413.84MB

01. Antimicrobial Pharmacology/04.09 Case Studies about Anti-HIV Agents – Antiviral Drugs.mp415.78MB

01. Antimicrobial Pharmacology/04.10 Anti-Herpes Agents Thymidine Kinase Agents – Antiviral Drugs.mp435.04MB

01. Antimicrobial Pharmacology/04.11 Anti-Herpes Agents RNA Polymerase Inhibitors and Other Drugs – Antiviral Drugs.mp423.04MB

01. Antimicrobial Pharmacology/04.12 Influenza Treatment – Antiviral Drugs.mp415.35MB

01. Antimicrobial Pharmacology/04.13 Hepatitis Treatment – Antiviral Drugs.mp444.01MB

01. Antimicrobial Pharmacology/04.14 Overview – Antiviral Agents and Treatment of CMV Retinitis – Antiviral Drugs.mp411.88MB

01. Antimicrobial Pharmacology/04.15 Case Study – Antiviral Drugs.mp441.6MB

01. Antimicrobial Pharmacology/05.01 Antimalarial Drugs – Antiprotozoal Agents.mp488.71MB

01. Antimicrobial Pharmacology/05.02 Amebicides – Antiprotozoal Agents.mp458.22MB

01. Antimicrobial Pharmacology/05.03 Nematicides – Antihelmintic Drugs.mp436.54MB

01. Antimicrobial Pharmacology/05.04 Trematocides (Praziquantel) and Cestodicides (Niclosamide) – Antihelmintic Drugs.mp415.42MB

01. Antimicrobial Pharmacology/05.05 Questions – Antiprotozoal and Antihelmintic Drugs.mp420.58MB

02. Pharmacokinetics and Pharmacodynamics/01.01 Introduction to Kinetics Pharmacokinetics (PK).mp432.04MB

02. Pharmacokinetics and Pharmacodynamics/01.02 Hydrophilic vs. Hydrophobic – Absorption and Distribution Pharmacokinetics (PK).mp427.02MB

02. Pharmacokinetics and Pharmacodynamics/01.03 pKa and Drug Solubility – Absorption and Distribution Pharmacokinetics (PK).mp436.57MB

02. Pharmacokinetics and Pharmacodynamics/01.04 Drug Distribution – Absorption and Distribution Pharmacokinetics (PK).mp436.55MB

02. Pharmacokinetics and Pharmacodynamics/01.05 Phases of Drug Development – Absorption and Distribution Pharmacokinetics (PK).mp438.58MB

02. Pharmacokinetics and Pharmacodynamics/02.01 Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp449.38MB

02. Pharmacokinetics and Pharmacodynamics/02.02 Factors Affecting Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4108.04MB

02. Pharmacokinetics and Pharmacodynamics/03.01 Introduction and Definitions of Pharmacodynamics – Pharmacodynamics.mp416.09MB

02. Pharmacokinetics and Pharmacodynamics/03.02 Drug Receptors and Effectors – Pharmacodynamics.mp417.01MB

02. Pharmacokinetics and Pharmacodynamics/03.03 Upregulation and Downregulation – Pharmacodynamics.mp45.39MB

02. Pharmacokinetics and Pharmacodynamics/03.04 Dose-Response, Binding, Quantal, Toxicity & Potency Curves – Pharmacodynamics.mp472.49MB

02. Pharmacokinetics and Pharmacodynamics/04.01 Introduction esp. Types of Eliminations – Elimination Kinetics.mp422.54MB

02. Pharmacokinetics and Pharmacodynamics/04.02 First Pass Metabolism – Elimination Kinetics.mp413.43MB

02. Pharmacokinetics and Pharmacodynamics/04.03 Bioavailability incl. Case Study – Elimination Kinetics.mp415.1MB

02. Pharmacokinetics and Pharmacodynamics/04.04 Dosage Calculation Maintenance Dose and Loading Dose – Elimination Kinetics.mp435.64MB

02. Pharmacokinetics and Pharmacodynamics/04.05 Intravenous vs. Oral Medications – Elimination Kinetics.mp48.71MB

02. Pharmacokinetics and Pharmacodynamics/04.06 Renal Clearance – Elimination Kinetics.mp432.69MB

03. Inflammation Pharmacology/01. Pharmacology of Inflammation.mp447.98MB

03. Inflammation Pharmacology/02. Acetylsalicylic Acid (ASA).mp431.37MB

03. Inflammation Pharmacology/03. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).mp420.6MB

03. Inflammation Pharmacology/04. COX-2 Inhibitors.mp415.69MB

03. Inflammation Pharmacology/05. Disease Modifying Anti Rheumatic Agents (DMARDS).mp444.98MB

03. Inflammation Pharmacology/06. Gout Medication Colchicine, Uric Acid and More.mp442.54MB

03. Inflammation Pharmacology/07. Inflammation Pharmacology Questions.mp427.3MB

04. Endocrine Pharmacology/01.01 Insulin – Diabetes Medications.mp419.07MB

04. Endocrine Pharmacology/01.02 Insulin Types & Glycemic Excursions – Diabetes Medications.mp425.11MB

04. Endocrine Pharmacology/01.03 Secretagogues and Biguanides – Diabetes Medications.mp427.98MB

04. Endocrine Pharmacology/01.04 Metformin, Alpha Glucosidase Inhibitors and Thiazolidinediones – Diabetes Medications.mp440.04MB

04. Endocrine Pharmacology/01.05 DPP-4 Inhibitors and GLP-1 Analogues – Diabetes Medications.mp428.04MB

04. Endocrine Pharmacology/01.06 SGLT2 Inhibitors – Diabetes Medications.mp450.16MB

04. Endocrine Pharmacology/01.07 Questions – Diabetes Medications.mp459.92MB

04. Endocrine Pharmacology/02.01 Overview – Adrenal Pharmacology.mp44.22MB

04. Endocrine Pharmacology/02.02 Mineralocorticoids and Glucocorticoids – Adrenal Pharmacology.mp449.8MB

04. Endocrine Pharmacology/02.03 Catecholamines – Adrenal Pharmacology.mp419.21MB

04. Endocrine Pharmacology/02.04 Questions and Case Studies – Adrenal Pharmacology.mp422.57MB

05. CNS - Pharmacology/01.01 Overview of Sedative and Hypnotic Drugs – Sedative Hypnotics.mp451.63MB

05. CNS - Pharmacology/01.02 Benzodiazepines – Sedative Hypnotics.mp433.35MB

05. CNS - Pharmacology/01.03 Barbiturates – Sedative Hypnotics.mp412.75MB

05. CNS - Pharmacology/01.04 Atypical Antipsychotic Drugs – Sedative Hypnotics.mp454.38MB

05. CNS - Pharmacology/01.05 Questions – Sedative Hypnotics.mp415.52MB

05. CNS - Pharmacology/01.06 Case Study – Sedative Hypnotics.mp421.39MB

05. CNS - Pharmacology/02.01 Overview – Antidepressants.mp414.49MB

05. CNS - Pharmacology/02.02 Monoamine Oxidase Inhibitors (MAOIs) – Antidepressants.mp423.58MB

05. CNS - Pharmacology/02.03 Tricyclic Antidepressants (TCAs) – Antidepressants.mp423.12MB

05. CNS - Pharmacology/02.04 Heterocyclic Antidepressants – Antidepressants.mp414.3MB

05. CNS - Pharmacology/02.05 SNRIs, Serotonin Antagonists and SSRIs – Antidepressants.mp452.57MB

05. CNS - Pharmacology/02.06 Review – Antidepressants.mp47.24MB

05. CNS - Pharmacology/02.07 Questions – Antidepressants.mp422.77MB

05. CNS - Pharmacology/03.01 Overview – Antipsychotics.mp49.09MB

05. CNS - Pharmacology/03.02 Effects of Increasing Dopamine – Antipsychotics.mp414.06MB

05. CNS - Pharmacology/03.03 Bipolar Disorder Medication – Antipsychotics.mp431.3MB

05. CNS - Pharmacology/03.04 Psychotic Disorder Medication – Antipsychotics.mp421.14MB

05. CNS - Pharmacology/03.05 Clinical Uses of Antipsychotics and Drug Induced Dyskinesia.mp424.68MB

05. CNS - Pharmacology/03.06 Questions – Antipsychotics.mp415.96MB

05. CNS - Pharmacology/04.01 Dopamine Hypothesis – Medication of Movement Disorders.mp419.82MB

05. CNS - Pharmacology/04.02 Dopamine Precursors and Agonists – Treatment of Movement Disorders.mp446.57MB

05. CNS - Pharmacology/04.03 MAO and COMT Inhibitors – Treatment of Movement Disorders.mp421.99MB

05. CNS - Pharmacology/04.04 Amantadine and Anticholinergics – Medication of Movement Disorders.mp416.48MB

05. CNS - Pharmacology/04.05 Postural Tremor, Huntington's Disease, Tourette's Syndrome, Wilsons's Disease and Drug Induced Dyskinesia – Medication of Movement Dis.mp435MB

05. CNS - Pharmacology/05.01 Overview – Anti-Seizure Medications.mp425.37MB

05. CNS - Pharmacology/05.02 Treatment Strategies – Anti-Seizure Medications.mp465.55MB

05. CNS - Pharmacology/05.03 Questions – Anti-Seizure Medications.mp422.01MB

05. CNS - Pharmacology/06.01 Overview – Anesthetic Drugs.mp44.94MB

05. CNS - Pharmacology/06.02 Inhaled Anesthetics – Anesthetic Drugs.mp430.42MB

05. CNS - Pharmacology/06.03 General Anesthetics – Anesthetic Drugs.mp441.59MB

05. CNS - Pharmacology/06.04 Intravenous Anesthetics – Anesthetic Drugs.mp424.45MB

05. CNS - Pharmacology/06.05 Case Study – Anesthetic Drugs.mp421.78MB

05. CNS - Pharmacology/07.01 Overview – Skeletal Muscle Relaxants.mp48.69MB

05. CNS - Pharmacology/07.02 Neuromuscular Blockers – Skeletal Muscle Relaxants.mp434.55MB

05. CNS - Pharmacology/07.03 Acute and Chronic Muscle Spasms – Skeletal Muscle Relaxants.mp433.21MB

05. CNS - Pharmacology/07.04 Questions – Skeletal Muscle Relaxants.mp434.64MB

05. CNS - Pharmacology/08.01 Overview – Local Anesthetics.mp439.75MB

05. CNS - Pharmacology/08.02 Esters and Amides – Local Anesthetics.mp432.95MB

05. CNS - Pharmacology/08.03 Overview – Opioid Analgesics.mp415.11MB

05. CNS - Pharmacology/08.04 Opioid Agonists – Opioid Analgesics.mp432.95MB

05. CNS - Pharmacology/08.05 Mixed AgonistsAntagonists and Antagonists – Opioid Analgesics.mp431.52MB

05. CNS - Pharmacology/08.06 Questions – Local Anesthetics and Opioid Analgesics.mp432.84MB

06. ANS - Pharmacology/01.01 Autonomic Nervous System (ANS) Overview.mp437.92MB

06. ANS - Pharmacology/01.02 Dual Innervation.mp423.14MB

06. ANS - Pharmacology/01.03 Alpha- and Beta-Blockers.mp430.18MB

06. ANS - Pharmacology/01.04 Sympathetic Blockers.mp428.71MB

06. ANS - Pharmacology/02.01 Cholinomimetic Activators.mp419.25MB

06. ANS - Pharmacology/02.02 Cholinomimetic Effects.mp437.52MB

06. ANS - Pharmacology/02.03 Special Topic Cholinergic Toxicity, Poisoning, Myestenia Crisis and Cholinergic Crisis.mp436.87MB

06. ANS - Pharmacology/03.01 Sympathomimetic Activators.mp430.33MB

06. ANS - Pharmacology/03.02 Sympathomimetic Effects.mp479.06MB

06. ANS - Pharmacology/03.03 Global Effect of Sympathomimetic Drugs on the Vascular System.mp437.12MB

06. ANS - Pharmacology/03.04 Anticholinergic Drugs.mp457.09MB

07. Respiratory Pharmacology/01. Asthma Medications.mp414.35MB

07. Respiratory Pharmacology/02. Bronchodilators.mp421.59MB

07. Respiratory Pharmacology/03. Corticosteroids.mp414.4MB

07. Respiratory Pharmacology/04. Leukotriene Receptor Antagonists.mp411.4MB

07. Respiratory Pharmacology/05. Anti-Inflammatory Agents Release Inhibitors and IgE-Antibodies.mp412.96MB

07. Respiratory Pharmacology/06. Asthma Medication Questions.mp416.18MB

08. Pharmacology of Blood Coagulation/01. Overview Coagulant Drugs.mp45.71MB

08. Pharmacology of Blood Coagulation/02. Antiplatelets.mp444.48MB

08. Pharmacology of Blood Coagulation/03. Anticoagulants.mp469.01MB

08. Pharmacology of Blood Coagulation/04. Thrombolytics and Procoagulants.mp439.01MB

08. Pharmacology of Blood Coagulation/05. Questions Coagulant Drugs.mp421.55MB

09. Gastrointestinal Pharmacology/01. Questions and Case Studies Steroids, Cyclosprine and Crohn's Disease.mp445.75MB

09. Gastrointestinal Pharmacology/02 Inflammatory Bowel Disease Medication.mp476.62MB

09. Gastrointestinal Pharmacology/03. Stomach Ulcer (Peptic Acid Disease) Medication.mp451.2MB

09. Gastrointestinal Pharmacology/04. Motility Disorder Medication.mp453.93MB

09. Gastrointestinal Pharmacology/05. Nausea Medication Antiemetics – Gastrointestinal Drugs.mp440.63MB

09. Gastrointestinal Pharmacology/06. Pancreatic Enzyme Replacement Therapy (PERT) and Gallstone Prevention – Gastrointestinal Drugs.mp416.88MB

09. Gastrointestinal Pharmacology/07. Irritable Bowel Syndrome (IBS) Medication.mp416.89MB

09. Gastrointestinal Pharmacology/08. Questions and Case Studies H2 Blockers, GERD Medication and Domperidone.mp418.88MB

10. Toxicology/03.05 Toxicology Questions & Case Studies.mp455.24MB

11. Cardiovascular Pharmacology/01.01 Introduction to High Blood Pressure Medication – Drugs in Hypertension.mp49.76MB

11. Cardiovascular Pharmacology/01.02 Diuretics – Drugs in Hypertension.mp456.44MB

11. Cardiovascular Pharmacology/01.03 Renin Angiotensin Aldosterone – Drugs in Hypertension.mp458.57MB

11. Cardiovascular Pharmacology/01.04 Vasodilators – Drugs in Hypertension.mp448.1MB

11. Cardiovascular Pharmacology/01.05 Alpha Blockers – Drugs in Hypertension.mp411.74MB

11. Cardiovascular Pharmacology/01.06 Beta Blockers – Drugs in Hypertension.mp429.15MB

11. Cardiovascular Pharmacology/01.07 Postganglionic Sympathetic Nerve Terminal Blockers and Monoamine Oxidase Inhibitors – Drugs in Hypertension.mp413.39MB

11. Cardiovascular Pharmacology/01.08 Lines of Therapy – Drugs in Hypertension.mp447.59MB

11. Cardiovascular Pharmacology/01.09 Pulmonary Hypertension Medication – Drugs in Hypertension.mp416.51MB

11. Cardiovascular Pharmacology/01.10 Questions and Case Studies – Drugs in Hypertension.mp433.77MB

11. Cardiovascular Pharmacology/02.01 Introduction – Angina and Heart Failure Management.mp415.62MB

11. Cardiovascular Pharmacology/02.02 Nitrates – Angina and Heart Failure Management.mp428.34MB

11. Cardiovascular Pharmacology/02.03 Cardiac Depressants, Metabolic Modifiers and Slow Sodium Channel Inhibitors – Angina and Heart Failure Management.mp421.11MB

11. Cardiovascular Pharmacology/02.04 Inotropes – Angina and Heart Failure Management.mp437.25MB

11. Cardiovascular Pharmacology/02.05 Vasodilators – Angina and Heart Failure Management.mp418.01MB

11. Cardiovascular Pharmacology/02.06 Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management.mp415.14MB

11. Cardiovascular Pharmacology/02.07 Questions – Angina and Heart Failure Management.mp439.23MB

11. Cardiovascular Pharmacology/03.01 Introduction – Antiarrhythmic Drugs.mp44.45MB

11. Cardiovascular Pharmacology/03.02 Group 1 Sodium Channel Blockers – Antiarrhythmic Drugs.mp432.74MB

11. Cardiovascular Pharmacology/03.03 Group 2 Beta Blockers – Antiarrhythmic Drugs.mp411.81MB

11. Cardiovascular Pharmacology/03.04 Group 3 Potassium Channel Blockers – Antiarrhythmic Drugs.mp423.91MB

11. Cardiovascular Pharmacology/03.05 Group 4 Calcium Channel Blockers – Antiarrhythmic Drugs.mp412.02MB

11. Cardiovascular Pharmacology/03.06 Group 5 Other Antiarrhythmics – Antiarrhythmic Drugs.mp424.87MB

11. Cardiovascular Pharmacology/03.07 Questions – Antiarrhythmic Drugs.mp421.42MB

11. Cardiovascular Pharmacology/04.01 Introduction Bile Acid Sequestrants, Niacin and Fibrates – Lipid Control.mp440.71MB

11. Cardiovascular Pharmacology/04.02 HMG-CoA Reductase Inhibitors – Lipid Control.mp463.37MB

11. Cardiovascular Pharmacology/04.03 Fat Absorption and MTP Inhibitors – Lipid Control.mp424.28MB

11. Cardiovascular Pharmacology/04.04 PCSK9 Inhibitors – Lipid Control.mp455.59MB

11. Cardiovascular Pharmacology/04.05 Questions – Lipid Control.mp418.96MB

12. Reproductive Pharmacology/01. Overview – Reproductive Pharmacology.mp410.31MB

12. Reproductive Pharmacology/02. Estrogens and Progestins – Reproductive Pharmacology.mp466.52MB

12. Reproductive Pharmacology/03. Anti-Estrogens and Antiprogestins – Reproductive Pharmacology.mp441.68MB

12. Reproductive Pharmacology/04. Androgens and Antiandrogens.mp440.67MB

12. Reproductive Pharmacology/05. Questions and Case Studies – Reproductive Pharmacology.mp420.81MB